Follow Us:
Saturday, November 27, 2021

Sun Pharma


Dilip Shanghvi resigns as MD of SPARC

May 26, 2021 2:05 pm

Shanghvi expressed his desire to step down and tendered his resignation as the MD with immediate effect, which was accepted by the board, Sun Pharma Advanced Research Company (SPARC) said in a regulatory filing.

Sun Pharma arm launches plaque psoriasis treatment drug in Japan

September 23, 2020 12:56 pm

In June this year, Sun Pharma said its subsidiary has got approval from the Japanese government for Ilumya.

Sun Pharma Q1 net loss at Rs 1,655.60 crore

July 31, 2020 5:28 pm

The company had posted a net profit of Rs 1,387.48 crore for the corresponding period of the previous fiscal, Sun Pharma said in a BSE filing.

Dadra unit of Sun Pharma shut after 18 employees test positive

July 03, 2020 6:13 pm

On Thursday evening, 17 employees tested positive, following which nearly 150 employees were quarantined in private hotels and hospitals in Silvassa. Those who tested positive are undergoing treatment in the government hospital in Silvassa.

Sun Pharma, Hikma ink exclusive pact for plaque psoriasis drug for MENA region

June 15, 2020 3:11 pm

Under the terms of the licensing agreement, Hikma will be responsible for the registration and commercialisation of the product in all MENA markets and Sun Pharma will be responsible for product supply, it added.

Sun Pharma board approves Rs 1,700 crore share buy-back offer

March 17, 2020 3:17 pm

Sun Pharmaceutical Industries said that the board of directors of the company, at its meeting held on Tuesday has approved the buy-back of its equity shares from the open market at a maximum price of Rs 425 per share.

Sun Pharma posts Q2 net profit of Rs 1,064.09 crore

November 07, 2019 6:13 pm

Sun Pharma said its active pharmaceutical ingredients (API) clocked external sales of Rs 468 crore, up 10 per cent over the same quarter last fiscal.

Sector scan: Sun Pharma set to shut down part of Vadodara R&D unit, 80 staff may lose jobs

August 03, 2019 4:30 am

In a letter to employees about the move, parts of which The Indian Express has viewed, Sun Pharmaceutical has announced it will shut down its Tandalja and Akota CPUs, part of the company’s Vadodara Research and Development (R&D) unit.

Sun Pharma tumbles on report of fresh allegations by whistleblower

January 18, 2019 12:01 pm

The complaint, sent to SEBI, is reportedly the second in over a month. The whistleblower alleges that Aditya Medisales Ltd had transactions with Suraksha Realty, controlled by Sun Pharma's co-promoter, Sudhir Valia.

Sun Pharma practices: questions, responses

December 07, 2018 9:32 am

Later, it was reported that a “potential whistleblower” too had raised such questions. Between November 30 and December 6, Sun’s stock price at the National Stock Exchange fell 14.7%.